Co-Authors
This is a "connection" page, showing publications co-authored by Manuel Battegay and Catia Marzolini.
Connection Strength
0.964
-
Sex Differences in Lopinavir Concentrations and Occurrence of Marked QTc Prolongation Episodes in Patients with COVID-19. Drug Saf. 2021 02; 44(2):255-257.
Score: 0.229
-
Stopping lopinavir/ritonavir in COVID-19 patients: duration of the drug interacting effect. J Antimicrob Chemother. 2020 10 01; 75(10):3084-3086.
Score: 0.226
-
Effect of Systemic Inflammatory Response to SARS-CoV-2 on Lopinavir and Hydroxychloroquine Plasma Concentrations. Antimicrob Agents Chemother. 2020 08 20; 64(9).
Score: 0.225
-
Prescribing in COVID-19 patients: Should we take into account inflammation? Br J Clin Pharmacol. 2021 03; 87(3):719-721.
Score: 0.225
-
Global Genomic Analysis of SARS-CoV-2 RNA Dependent RNA Polymerase Evolution and Antiviral Drug Resistance. Microorganisms. 2021 May 19; 9(5).
Score: 0.059